News & Events

LSIE 2014 will offer a platform of professional conferences and exhibition, which will showcase all the research and development stages, in the Israeli Life Sciences industry, which is world renowned for its innovation, ingenuity and creativity.

Reports on Inventions, Patents, License Agreements, Revenues and Startup Companies.
The survey of commercialization companies in Israel for 2012- 2013 includes those companies associated with research universities (eight companies for the eight universities), and companies associated with hospitals and research institutions. This is the third survey conducted on commercialization companies.

Israel prime-minister Benjamin Netanyahu and Ben-Gurion University of the Negev president Rivka Carmi earlier this week announced the establishment of a national cyber complex in Beer-Sheva, called CyberSpark.

IBM and Ben-Gurion University of the Negev announced their intention to establish a Center of Excellence for Security and Protection of Infrastructure and Assets, located in Beer-Sheva, Israel. This new joint venture will perform leading edge scientific research on emerging areas like Big Data and cloud computing.

Lockheed Martin (NYSE: LMT) and EMC Corporation (NYSE: EMC) plan to invest together in advanced technology projects based in the Advanced Technologies Park in Beer-Sheva, Israel. An official launch ceremony for the agreement took place in Tel Aviv, at the CyberTech 2014 International Exhibition and Conference, sponsored by the Israeli National Cyber Bureau.

Yixing,Jiangsu China, November 14, 2013 Amir Naiberg, the CEO of Weizmann Institute of Science’s commercialization arm,Yeda Research & Development, and Mr. Tang Shunliang, the Chairman of Jianghua Group today signed two technology licensing agreements,aiming at cooperating in development, commercialization and localization of two technologies targeting contaminated water treatment in China.

German Telecommunications Giant Lauds Successful Research Cooperation.
Ben-Gurion University of the Negev dedicated the expanded Deutsche Telekom Innovation Laboratories in the presence of both the outgoing and incoming CEOs of the German Telecommunications giant Deutsche Telekom AG on Tuesday morning in Beer-Sheva.

The state is laying the foundations for better and more productive economic and research collaborations between Connecticut and Israeli businesses, research institutions and universities.
Connecticut’s Department of Economic and Community Development (DECD) and the Israel Tech Transfer Organization (ITTN) today announced that they have entered into a Memorandum of Understanding (MoU), the first step in developing relationships that will increase the commercial and scientific ties between Connecticut and Israel.

“This is a day that will change the history of the State of Israel and we are doing it here in Beer-Sheva!” Prime Minister Binyamin Netanyahu declared at the launch of the Advanced Technologies Park today. Netanyahu was accompanied by Energy and Water, Regional Cooperation and Negev and Galilee Development Minister Silvan Shalom, and Transportation, National Infrastructures and Road Safety Minister Yaakov Katz. MKs Prof. Avishay Braverman and Erel Margalit were also in attendance.

Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and BGN Technologies. announced today that they have entered into an option and license agreement covering several fully human anti-Hepatitis C Virus (HCV) antibody clones identified, in the laboratory of Dr. Leslie Lobel, M.D., Ph.D., from patients who have recovered from HCV infections. Sorrento plans to develop these early findings into a potential therapeutic product. This collaborative effort utilizes the respective strengths of each organization to create an important product opportunity consisting of therapeutic and/or prophylactic agents against HCV infections. Sorrento will be responsible for developing the perspective anti-HCV antibody products.